Skip to main content
Fig. 3 | EJNMMI Research

Fig. 3

From: [18F]FE-PE2I DAT correlates with Parkinson’s disease duration, stage, and rigidity/bradykinesia scores: a PET radioligand validation study

Fig. 3

Correlations of the three clinical measures with the hypothesized and exploratory nigrostriatal regions combined, in the total group (n = 41, column A) and the clinically assessed ‘OFF’ subgroup (n = 23 two columns of B). ρ: Spearman’s rho; ROI: region of interest; CAU: caudate nucleus; PUT; putamen; SMS; sensorimotor striatum; SN: substantia nigra. P value cut-off for post hoc analysed regions 0.019 (correcting for multiple comparisons for four regions with calculated meff: 0.05/2.63)

Back to article page